by Rawamino | Dec 1, 2025 | Peptides
Introduction Repair of injured tissues in experimental systems requires coordinated control of cell migration, extracellular-matrix (ECM) remodeling, angiogenesis, and inflammatory resolution. Multiple peptide derivatives are being evaluated as probes to modulate...
by Rawamino | Dec 1, 2025 | Peptides
Introduction Age-associated remodeling of the hypothalamic–pituitary–somatotropic (HPS) axis is characterized in laboratory models by attenuated growth hormone (GH) pulsatility, altered feedback sensitivity, and downstream shifts in energy allocation, tissue turnover,...
by Rawamino | Nov 30, 2025 | Peptides
Introduction Cellular “energy” in biological research spans coordinated processes from mitochondrial ATP production to neuromodulatory states that bias vigilance, motivation, and motor output. Fatigue-like phenotypes in laboratory models often reflect composite...
by Rawamino | Nov 30, 2025 | Peptides
Introduction Solid-tissue tumors in laboratory models often exhibit reprogrammed membrane composition and stress-adapted surveillance pathways. Among these, the p53–MDM2 (HDM2 in human sequence nomenclature) axis is a central quality-control system that constrains...
by Rawamino | Nov 29, 2025 | Peptides
Introduction Sexual motivation and arousal emerge from distributed neural computations that integrate homeostatic state, reward valuation, and sensory input. A long-standing question in basic neuroendocrinology is how peptidergic signals couple these computations to...
